https://orcid.org/0000-0003-1909-1072
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mai H. ElNaggar, Abdullah A. Elgazar, Ghada Gamal, Shimaa M. Hamed, Zainab M. Elsayed, Mohamed K. El-Ashrey, Amira Abood, Mahmoud A. El Hassab, Ahmed M. Soliman, Ramadan A. El-Domany, Farid A. Badria, Claudiu T. Supuran & Wagdy M. Eldehna. (2023) Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A. Ewes, Mashooq Ahmad Bhat, Noha I. Ziedan, Hamed W. El-Shafey, Ahmed A. B. Mohamed, Mohamed R. Elnagar, Abdullah Haikal, Dina I. A. Othman, Abdullah A. Elgazar, Ahmed H. A. Abusabaa, Kamal S. Abdelrahman, Osama M. Soltan & Mostafa M. Elbadawi. (2023) Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Mona H. Ibraheim, Ibrahim Maher & Ibrahim Khater. (2023) ‘In silico’ repurposing new inhibitors of EGFR and VEGFR-2 kinases via biophysical mechanisms. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-16.
Read now
Read now
Sunil Kumar, Iqra Ali, Faheem Abbas, Anurag Rana, Sadanand Pandey, Manoj Garg & Deepak Kumar. (2023) In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-23.
Read now
Read now
Articles from other publishers (17)
Shimaa A. Abass, Abdullah A. Elgazar, Sanad S. El-kholy, Amal I. El-Refaiy, Reem A. Nawaya, Mashooq Ahmad Bhat, Foad A. Farrag, Abdelrahman Hamdi, Marwa Balaha & Mohammed A. El-Magd. (2024) Unraveling the Nephroprotective Potential of Papaverine against Cisplatin Toxicity through Mitigating Oxidative Stress and Inflammation: Insights from In Silico, In Vitro, and In Vivo Investigations. Molecules 29:9, pages 1927.
Crossref
Crossref
Ulviye Acar Çevik, Betül Kaya, Ismail Celik, Mithun Rudrapal, Gourav Rakshit, Arzu Karayel, Serkan Levent, Derya Osmaniye, Begüm Nurpelin Sağlık Özkan, Merve Baysal, Özlem Atlı Ekliog̈lu, Yusuf Özkay & Zafer Asım Kaplancıklı. (2024) New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies. ACS Omega.
Crossref
Crossref
Marwa I. Serag, Samar S. Tawfik, Sahar M. I. Badr & Hassan M. Eisa. (2024) New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study. Scientific Reports 14:1.
Crossref
Crossref
Alaa M. Ali, Samar S. Tawfik, Bhoomendra A. Bhongade, Mohammed A.M. Massoud & Amany S. Mostafa. (2024) Design, synthesis, and in silico insights into dual-inhibition of CDK-6/Aurora A kinase by 2-phenylbenzimidazole-based small molecules. Journal of Molecular Structure 1300, pages 137215.
Crossref
Crossref
Mohamed A. Zeidan, Dina I. A. Othman, Fatma E. Goda & Amany S. Mostafa. (2023) Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction. Archiv der Pharmazie 357:3.
Crossref
Crossref
Nareman A. Nawareg, Amany S. Mostafa, Shahenda M. El-Messery & Magda N.A. Nasr. (2024) Benzimidazole based hybrids as privileged candidates for topoII inhibition: Design, synthesis and molecular modeling studies. Journal of Molecular Structure 1298, pages 137020.
Crossref
Crossref
Anuradha Mehra & Rekha Sangwan. (2023) Synthesis and Pharmacological Properties of the Benzimidazole Scaffold: A Patent Review. ChemistrySelect 8:45.
Crossref
Crossref
Mohamed Adardour, Marouane Ait Lahcen, Ismail Hdoufane, Mohammed M. Alanazi, Mohamed Loughzail, Hénia Mousser, Solenne Fleutot, Michel François, Driss Cherqaoui & Abdesselam Baouid. (2023) Crystal Structure, DFT Calculation, and Hirshfeld Surface Analysis of the 1-(Cyclohex-1-en-1-yl)-3-(prop-2-yn-1-yl)-1,3-dihydro-2H-benzimidazol-2-one. Crystals 13:12, pages 1661.
Crossref
Crossref
Leqaa A. Mohammed, Mohammed Alwan Farhan, Safaa A. Dadoosh, Mustafa A. Alheety, Abdulwahhab H. Majeed, Ali Saadon Mahmood & Zaid H. Mahmoud. (2023) A Review on Benzimidazole Heterocyclic Compounds: Synthesis and Their Medicinal Activity Applications. SynOpen 07:04, pages 652-673.
Crossref
Crossref
Dina I.A. Othman, Abdelrahman Hamdi, Walaa M. Elhusseiny, Adel S. El-Azab, Ahmed H. Bakheit, Mohamed Hefnawy & Alaa A.-M. Abdel-Aziz. (2023) Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study. Saudi Pharmaceutical Journal 31:11, pages 101803.
Crossref
Crossref
Abdullah A. Elgazar, Ramadan A. El-Domany, Wagdy M. Eldehna & Farid A. Badria. (2023) 3-Acetyl-11-keto-β-boswellic Acid-Based Hybrids Alleviate Acetaminophen-Induced Hepatotoxicity in HepG2 by the Regulation of Inflammatory and Oxidative Stress Pathways: An Integrated Approach. ACS Omega 8:42, pages 39490-39510.
Crossref
Crossref
Ahmed K. B. Aljohani, Waheed Ali Zaki El Zaloa, Mohamed Alswah, Mohamed A. Seleem, Mohamed M. Elsebaei, Ashraf H. Bayoumi, Ahmed M. El-Morsy, Mohammed Almaghrabi, Aeshah A. Awaji, Ali Hammad, Marwa Alsulaimany & Hany E. A. Ahmed. (2023) Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies. International Journal of Molecular Sciences 24:19, pages 15026.
Crossref
Crossref
Keshav Taruneshwar Jha, Abhimannu Shome, Chahat & Pooja A Chawla. (2023) Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship. Bioorganic Chemistry 138, pages 106680.
Crossref
Crossref
Shankaraiah Ambala, Vishnu Thumma, Veerabhadraiah Mallikanti, Shalini Aitha, Raghavender Matta & Jalapathi Pochampally. (2023) Design, Synthesis, and Cytotoxicity of Some New Benzimidazole‐Piperazine Conjugate Analogues Against Human Breast Adenocarcinoma. ChemistrySelect 8:31.
Crossref
Crossref
Maria Marinescu. (2023) Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review. Antibiotics 12:7, pages 1220.
Crossref
Crossref
Veerabhadraiah Mallikanti, Vishnu Thumma, Raghavender Matta, Krishna Reddy Valluru, Lakshmi Narayana Sharma Konidena, Lakshmi Satya Boddu & Jalapathi Pochampally. (2023) Synthesis, antimicrobial activity and molecular docking of novel benzimidazole conjugated 1,2,3-triazole analogues. Chemical Data Collections 45, pages 101034.
Crossref
Crossref
Srinivas Gali, D. Raghu, Veerabhadraiah Mallikanti, Vishnu Thumma & Namratha Vaddiraju. (2023) Design, synthesis of benzimidazole tethered 3,4-dihydro-2H-benzo[e] [1, 3] oxazines as anticancer agents. Molecular Diversity.
Crossref
Crossref